September 10, 2015

Clinical trial seeks adults diagnosed with mild to moderate Alzheimer's disease

The Vanderbilt Memory and Alzheimer's Center is recruiting adults age 55 to 85 with mild to moderate Alzheimer's disease to participate in the NOBLE Study.

The study will test whether an investigational drug (called T-817) is safe and beneficial in delaying declines in memory and daily function in individuals with Alzheimer's disease.

Participants will attend a visit to Vanderbilt University Medical Center once every few weeks for 12 total visits over 14 months. Study procedures include blood work, physical exam, memory testing and heart testing. Participants complete a brain MRI scan twice, once at the beginning of the study and once at the end of the study.

Individuals are not eligible to participate if they have ever experienced a significant head injury or major stroke, if they have a history of alcohol or substance abuse in the past five years or if they have a history of a major psychiatric illness, such as bipolar disorder or schizophrenia.

There is no cost for participating in the study.

For more information about participating in this trial, please fill out a brief survey using the following link,